Evidence map›Paper›PMID 18653244›Full record

ArticleJournal of neuroimmunology2008

Ingress of blood-borne macrophages across the blood-brain barrier in murine HIV-1 encephalitis.

Yutong Liu, Mariano G Uberti, Huanyu Dou, Rebecca Banerjee, Cassi B Grotepas, David K Stone, Barrett E Rabinow, Howard E Gendelman, Michael D Boska

Abstract read
In one paragraph

Article in Journal of neuroimmunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Neuroimmune pharmacology as a sub-discipline of medical neuroscience in the medical school curriculum.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2011
    Review
  7. Article
  8. Article
  9. NanoART, neuroAIDS and CNS drug delivery.Nanomedicine (London, England) · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yutong LiuCenter for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, NE 68198-5880, United States.
Mariano G Uberti
Huanyu Dou
Rebecca Banerjee
Cassi B Grotepas
David K Stone
Barrett E Rabinow
Howard E Gendelman
Michael D Boska

Funding

VIRAL SHUTOFF OF HOST TRANSCRIPTION--PBCV-1 INFECTEDP20RR015635 · NCRR · UNIVERSITY OF NEBRASKA LINCOLN · PI WOOD, CHARLES · 2000 to 2009
$22.1M
Targeted Neuro Protection of HIV-1 Associated Neurologic DiseaseP01MH064570 · NIMH · UNIVERSITY OF ROCHESTER · PI GELBARD, HARRIS A · 2001 to 2014
$19.4M
Immunopathogenesis of HIV Neurological DisordersU54NS043011 · NINDS · UNIVERSITY OF PUERTO RICO MED SCIENCES · PI KRAISELBURD, EDMUNDO NELSON · 2001 to 2011
$14.6M
Neuroprotective Immunity and HIV DementiaR01NS034239 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI Howard E Gendelman, R Lee Mosley · 1995 to 2026
$12.3M
Proteomics CoreP01NS043985 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI ZHENG, JIALIN CHARLES · 2003 to 2012
$11.8M
Role of EAAT2 and AEG-1 in Astrocyte Dysfunction and NeurodegenerationP01NS031492 · NINDS · ST. LUKE'S-ROOSEVELT INST FOR HLTH SCIS · PI GELBARD, HARRIS A · 1993 to 2007
$10.9M
Nanomedicine and NeuroAIDSR01NS036126 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E · 1997 to 2017
$5.7M
Blood Brain Barrier Physiology and HIV DementiaR37NS036126 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E. · 2001 to 2007
$2.7M
Training Program in NeurovirologyT32NS007488 · NINDS · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI GENDELMAN, HOWARD E. · 2002 to 2006
$776k
NCRR NIH HHS P20 RR015635NCRR NIH HHS P20 RR15635NIMH NIH HHS P01 MH064570NIMH NIH HHS P01MH64570NINDS NIH HHS 1054 NS43011NINDS NIH HHS P01 NS043985NINDS NIH HHS P01 NS31492NINDS NIH HHS P01 NS 43985NINDS NIH HHS R01 NS034239NINDS NIH HHS R01 NS036126NINDS NIH HHS R37 NS036126NINDS NIH HHS R37 NS36126NINDS NIH HHS T32 NS007488
6 · The paper itself

Abstract

Blood-borne macrophage ingress into brain in HIV-1 associated neurocognitive disorders governs the tempo of disease. We used superparamagnetic iron-oxide particles loaded into murine bone marrow-derived macrophages (BMM) injected intravenously into HIV-1 encephalitis mice to quantitatively assess BMM entry into diseased brain regions. Magnetic resonance imaging tests were validated by histological coregistration and enhanced image processing. The demonstration of robust BMM migration into areas of focal encephalitis provide 'proof of concept' for the use of MRI to monitor macrophage ingress into brain.

Indexed as

AnimalsBlood-Brain BarrierCell MovementDisease Models, AnimalEncephalitisGlial Fibrillary Acidic ProteinHIV InfectionsImaging, Three-DimensionalMacrophagesMagnetic Resonance ImagingMaleMiceMice, SCIDVimentinGlial Fibrillary Acidic ProteinVimentin

Identifiers

PMID18653244
PMCPMC2572762

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.